Cargando…
Isoform-specific characterization of class I histone deacetylases and their therapeutic modulation in pulmonary hypertension
Pharmacological modulation of class I histone deacetylases (HDAC) has been evaluated as a therapeutic strategy for pulmonary hypertension (PH) in experimental models of PH. However, information of their expression, regulation and transcriptional targets in human PH and the therapeutic potential of i...
Autores principales: | Chelladurai, Prakash, Dabral, Swati, Basineni, Sobha Rani, Chen, Chien-Nien, Schmoranzer, Mario, Bender, Nina, Feld, Christine, Nötzold, René Reiner, Dobreva, Gergana, Wilhelm, Jochen, Jungblut, Benno, Zhao, Lan, Bauer, Uta-Maria, Seeger, Werner, Pullamsetti, Soni Savai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393135/ https://www.ncbi.nlm.nih.gov/pubmed/32733053 http://dx.doi.org/10.1038/s41598-020-69737-x |
Ejemplares similares
-
Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives
por: Chelladurai, Prakash, et al.
Publicado: (2016) -
Zooming into Cellular and Molecular Heterogeneity of Pulmonary Hypertension. What More Single-Cell Omics Can Offer
por: Chelladurai, Prakash, et al.
Publicado: (2021) -
Cancer and pulmonary hypertension: Learning lessons and real-life interplay
por: Pullamsetti, Soni Savai, et al.
Publicado: (2020) -
A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
por: Dabral, Swati, et al.
Publicado: (2019) -
Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis
por: Rubio, Karla, et al.
Publicado: (2019)